These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1830235)

  • 21. The effect of SB-269970, a 5-HT(7) receptor antagonist, on 5-HT release from serotonergic terminals and cell bodies.
    Roberts C; Allen L; Langmead CJ; Hagan JJ; Middlemiss DN; Price GW
    Br J Pharmacol; 2001 Apr; 132(7):1574-80. PubMed ID: 11264252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-Hydroxytryptamine3 receptors sited on cholinergic axon terminals of human cerebral cortex mediate inhibition of acetylcholine release.
    Maura G; Andrioli GC; Cavazzani P; Raiteri M
    J Neurochem; 1992 Jun; 58(6):2334-7. PubMed ID: 1533419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic 5-HT2 receptor antagonist treatment alters 5-HT1A autoregulatory control of 5-HT release in rat brain in vivo.
    Kidd EJ; Leysen JE; Marsden CA
    J Neurosci Methods; 1990 Sep; 34(1-3):91-8. PubMed ID: 1701842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-HT3 receptor-active drugs alter development of spinal serotonergic innervation: lack of effect of other serotonergic agents.
    Bell J; Zhang XN; Whitaker-Azmitia PM
    Brain Res; 1992 Feb; 571(2):293-7. PubMed ID: 1535269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonin-2 receptor-mediated regulation of release of acetylcholine by minaprine in cholinergic nerve terminal of hippocampus of rat.
    Muramatsu M; Tamaki-Ohashi J; Usuki C; Araki H; Aihara H
    Neuropharmacology; 1988 Jun; 27(6):603-9. PubMed ID: 3419543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of chronic chlorimipramine treatment on the serotonergic modulation of acetylcholine release from guinea pig caudate nucleus slices.
    Siniscalchi A; Beani L; Bianchi C
    Neuropharmacology; 1990 Nov; 29(11):1091-3. PubMed ID: 2087259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo modulation of acetylcholine in the nucleus accumbens of freely moving rats: I. Inhibition by serotonin.
    Rada PV; Mark GP; Hoebel BG
    Brain Res; 1993 Aug; 619(1-2):98-104. PubMed ID: 8374797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype.
    Schoeffter P; Hoyer D
    J Pharmacol Exp Ther; 1990 Jan; 252(1):387-95. PubMed ID: 2137176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
    Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-HT1A receptor-mediated inhibition of acetylcholine release from guinea pig myenteric plexus: potential mechanisms.
    Dietrich C; Kilbinger H
    Neuropharmacology; 1996 Apr; 35(4):483-8. PubMed ID: 8793911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
    Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
    J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors.
    Clarke RW; Ogilvie J; Houghton AK
    Br J Pharmacol; 1997 Oct; 122(4):631-8. PubMed ID: 9375958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of chronic treatment with 5-HT1 agonist (8-OH-DPAT and RU 24969) and antagonist (isapirone) drugs on the behavioural responses of mice to 5-HT1 and 5-HT2 agonists.
    De Souza RJ; Goodwin GM; Green AR; Heal DJ
    Br J Pharmacol; 1986 Oct; 89(2):377-84. PubMed ID: 2946344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-HT1A receptors and the tail-flick response. IV. Spinally localized 5-HT1A receptors postsynaptic to serotoninergic neurones mediate spontaneous tail-flicks in the rat.
    Bervoets K; Rivet JM; Millan MJ
    J Pharmacol Exp Ther; 1993 Jan; 264(1):95-104. PubMed ID: 8423555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
    Chaouloff F; Jeanrenaud B
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia.
    Bill DJ; Knight M; Forster EA; Fletcher A
    Br J Pharmacol; 1991 Aug; 103(4):1857-64. PubMed ID: 1833017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
    Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V
    J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the 5-HT receptors mediating contractions in the rabbit isolated renal artery.
    Tadipatri S; van Heuven-Nolsen D; Feniuk W; Saxena PR
    Br J Pharmacol; 1991 Dec; 104(4):887-94. PubMed ID: 1667289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.